Safety, Tolerability, and Pharmacokinetics of SPL84 in Healthy Volunteers

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure

NCT06746064 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis

NCT03309358 ·Status: TERMINATED ·Phase: PHASE1

A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects

NCT05154240 ·Status: COMPLETED ·Phase: PHASE1

Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects

NCT02468908 ·Status: COMPLETED ·Phase: PHASE1

Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)

NCT07048262 ·Status: RECRUITING ·Phase: PHASE2

SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects

NCT03669614 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation

NCT04656275 ·Status: TERMINATED ·Phase: PHASE1

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects

NCT04488705 ·Status: COMPLETED ·Phase: PHASE1

A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNS-3545 in Healthy Participants

NCT07225296 ·Status: RECRUITING ·Phase: PHASE1

Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis

NCT01818544 ·Status: COMPLETED ·Phase: PHASE2

Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects

NCT00125346 ·Status: TERMINATED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis

NCT01362231 ·Status: COMPLETED ·Phase: PHASE1

Aerosol Cyclosporine in Chronic Obstructive Pulmonary Disease (COPD)

NCT00783107 ·Status: COMPLETED ·Phase: PHASE1

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

NCT04308681 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

NCT07201051 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

NCT01766817 ·Status: COMPLETED ·Phase: PHASE2

Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta

NCT07108153 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects

NCT04926701 ·Status: COMPLETED ·Phase: PHASE1

Two-Part Study to Evaluate the Dose Response of SCH 527123 on Sputum Neutrophilia Following Ozone Challenge in Healthy Subjects and Chronic Obstructive Pulmonary Disease (COPD) Patients (P05567 AM7)

NCT01068145 ·Status: TERMINATED ·Phase: PHASE1

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD).

NCT05513950 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers

NCT06482190 ·Status: RECRUITING ·Phase: PHASE1

A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects

NCT01793649 ·Status: TERMINATED ·Phase: PHASE1

Scleroderma Lung Disease

NCT00004563 ·Status: COMPLETED ·Phase: PHASE3

Effects of CSL324 in the Lung After Segmental Challenge

NCT05653713 ·Status: COMPLETED ·Phase: PHASE1

A First in Human Study of the Safety, Tolerability, and the Physiologically Based Pharmacokinetics of XFB19 in Healthy Adult Volunteers.

NCT05361733 ·Status: RECRUITING ·Phase: PHASE1